Skip to main content
. 2023 Feb 11;20:28. doi: 10.1186/s12985-023-01978-4

Fig. 2.

Fig. 2

The disease course of the two relapse patients. (a) Patient A; (b) Patient C. lym(#) lymphocyte count, ALT alanine transaminase, CRP C‐reactive protein, TAC tacrolimus, PA prednisone acetate, CsA cyclosporin A, MMF mycophenolate mofetil, q12h every 12 h, qd every day